Avitide's Series C Round

Avitide raised a round of funding on August 06, 2015.

Avitide delivers on-demand, molecule-specific biopharmaceutical affinity purification solutions with an industry-leading 3-month service. Avitide's proprietary affinity separation technology enables o…

Articles about Avitide's Series C Round: